Aurinia Pharmaceuticals Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$83,220	$77,705	$77,114	$73,468
Gross Profit	76,665	71,200	68,642	64,964
EBITDA	54,568	49,753	47,068	36,827
EBIT	49,734	44,937	42,204	31,962
Net Income	37,414	34,355	210,794	31,551
Net Change In Cash	83,220	77,705	77,114	73,468
Free Cash Flow	52,170	32,521	44,501	44,384
Cash	179,832	41,008	80,213	73,189
Basic Shares	133,530	137,639	138,700	136,008

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$283,055	$235,133	$175,513	$134,030
Gross Profit	250,390	206,885	161,365	128,366
EBITDA	127,757	31,728	-63,047	-108,764
EBIT	118,487	12,283	-74,694	-111,470
Net Income	287,202	5,752	-78,020	-108,180
Net Change In Cash	283,055	235,133	175,513	134,030
Free Cash Flow	135,406	44,107	-34,179	-79,821
Cash	80,213	83,433	48,875	94,172
Basic Shares	138,700	146,194	143,236	141,915